Status:
COMPLETED
Intestinal Microbiome and Extremes of Atherosclerosis
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Gastrointestinal Microbiome, Atherosclerosis, Nutrients
Renal Function
Eligibility:
All Genders
18+ years
Brief Summary
Patients attending stroke prevention clinics and a premature atherosclerosis clinic at University Hospital in London, ON, Canada were recruited to the study. They completed a dietary questionnaire, pr...
Detailed Description
Patients were phenotyped by their residual score in linear multiple regression with measured carotid plaque burden as the dependent variable and coronary risk factors were predictors. The residual sco...
Eligibility Criteria
Inclusion
- Patients attending stroke prevention clinics and a Premature Atherosclerosis Clinic at University Hospital, London, ON, Canada,
- with measurements of carotid plaque burden and the risk factors used in the linear regression model.
- Willing to consent to the protocol approved by the Ethics board
Exclusion
- Missing data on variables used in the regression model,
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2016
Estimated Enrollment :
316 Patients enrolled
Trial Details
Trial ID
NCT03398889
Start Date
July 1 2014
End Date
October 15 2016
Last Update
January 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stroke Prevention & Atherosclerosis Research Centre
London, Ontario, Canada, N6G 2V4